Orange Book product · Generic (ANDA)
ERTAPENEM SODIUM
ERTAPENEM SODIUM
At a glance
May 02, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
May 02, 2023
3 yr 2 mo ago
Today
Pharmaceutical detail
Active ingredient
ERTAPENEM SODIUM
Strength
EQ 1GM BASE/VIAL
Dosage form
INJECTABLE
Route
INTRAMUSCULAR, INTRAVENOUS
TE code
Not listed
Application
ANDA 209145
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of ERTAPENEM SODIUM
- 2001INVANZBrand (NDA)
NDA 021337 · MSD SUB MERCK
- 2024ERTAPENEM SODIUMGeneric (ANDA)
ANDA 218067 · QILU ANTIBIOTICS
- 2021ERTAPENEM SODIUMGeneric (ANDA)
ANDA 212040 · GLAND
- 2019ERTAPENEM SODIUMGeneric (ANDA)
ANDA 207647 · SAVIOR LIFETEC CORP
- 2018ERTAPENEM SODIUMGeneric (ANDA)
ANDA 209133 · EUGIA PHARMA
- 2018ERTAPENEM SODIUMGeneric (ANDA)
ANDA 208790 · ACS DOBFAR SPA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
